Phosphine

Phosphine

SCHEMBL348470

P.P.P

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27280481 1.00
Phosphine SCHEMBL9725482 1.00
Phosphine SCHEMBL28328516 1.00
Phosphine SCHEMBL31621074 1.00
Phosphine SCHEMBL9725473 1.00
Phosphine SCHEMBL68 1.00
Phosphine SCHEMBL29350820 1.00
Phosphine SCHEMBL52248 1.00
Phosphine SCHEMBL959042 1.00
Phosphine SCHEMBL27948234 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0601486-A1 Cis-epoxide derivatives useful as irreversible HIV protease inhibitors and process and intermediates for their preparation LUCKY LTD. (KR) 1994-06-15 EP claimed
EP-4342487-A2 PHARMACEUTICAL COMPOSITION COMPRISING GIP DERIVATIVE OR LONG-ACTING CONJUGATE THEREOF FOR PREVENTING OR TREATING PULMONARY DISEASE Hanmi Pharm. Co., Ltd. (KR) 2024-03-27 EP disclosed
US-11872262-B2 Means and methods for treating bacterial infections VIB VZW (BE) 2024-01-16 US disclosed
US-20230382970-A1 GLP-1/GIP DUAL AGONIST, LONG-ACTING CONJUGATE THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME HANMI PHARM. CO., LTD. (KR) 2023-11-30 US disclosed
US-20230381279-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LUPUS-RELATED DISEASES COMPRISING GIP DERIVATIVE OR LONG-ACTING CONJUGATE THEREOF HANMI PHARM. CO., LTD. (KR) 2023-11-30 US disclosed
US-20230381331-A1 GIP DERIVATIVE, LONG-ACTING CONJUGATE THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME HANMI PHARM. CO., LTD. (KR) 2023-11-30 US disclosed
US-20230381281-A1 PHARMACEUTICAL COMPOSITION COMPRISING GLUCAGON/GLP-1/GIP TRIPLE AGONIST OR LONG-ACTING CONJUGATE THEREOF FOR PREVENTING OR TREATING LUPUS-RELATED DISEASES HANMI PHARM. CO., LTD. (KR) 2023-11-30 US disclosed
US-20230381333-A1 PHARMACEUTICAL COMPOSITION COMPRISING GLUCAGON/GLP-1/GIP TRIPLE AGONIST OR LONG-ACTING CONJUGATE THEREOF FOR PREVENTING OR TREATING VASCULITIS HANMI PHARM. CO., LTD. (KR) 2023-11-30 US disclosed
US-11795583-B2 Plasticized melt spinning process using ionic liquids for production of polyacrylonitrile fibers UT-BATTELLE, LLC (US) 2023-10-24 US disclosed
CN-116847868-A Pharmaceutical composition comprising GIP derivative or long-acting conjugate thereof for preventing or treating pulmonary diseases 韩美药品株式会社 2023-10-03 CN disclosed
EP-1221830-A4 EXPRESSION OF PHYTASE IN PLANTS AS A METHOD OF MODIFYING PLANT PRODUCTIVITY COMMW SCIENT IND RES ORG (AU) 2004-06-16 EP disclosed
EP-1416000-A1 Process for preparing low molecular weight olefin (co)polymer and polymerizing catalyst used therefor Mitsui Chemicals, Inc. (JP) 2004-05-06 EP disclosed
EP-1270585-A1 PEPTIDE DERIVATIVE Takeda Chemical Industries, Ltd. (JP) 2003-01-02 EP disclosed
EP-1221830-A1 EXPRESSION OF PHYTASE IN PLANTS AS A METHOD OF MODIFYING PLANT PRODUCTIVITY COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2002-07-17 EP disclosed
US-20010056136-A1 Polymer composite KENKYUSHO, KABUSHIKI (JP) 2001-12-27 US disclosed
WO-2001022806-A1 EXPRESSION OF PHYTASE IN PLANTS AS A METHOD OF MODIFYING PLANT PRODUCTIVITY COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2001-04-05 WO disclosed
US-5763631-A CIS-EPOXIDE COMPOUNDS; ANTIVIRUS AGENTS; USEFUL TO TREAT THE AIDS LUCKY LIMITED (KR) 1998-06-09 US disclosed
US-5744621-A CIS-EPOXIDE COMPOUNDS LUCKY LIMITED. (KR) 1998-04-28 US disclosed
US-5587388-A AIDS; VIRICIDES LUCKY LIMITED (KR) 1996-12-24 US disclosed
EP-0601486-A1 Cis-epoxide derivatives useful as irreversible HIV protease inhibitors and process and intermediates for their preparation LUCKY LTD. (KR) 1994-06-15 EP disclosed